Paul Jeng

Stock Analyst

(n/a)

# 4,728

Out of 4,987 analysts

3

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Stocks Rated by Paul Jeng

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IMTX Immatics	Initiates: Buy	$16	$6.03	+165.34%	1	Sep 18, 2025
	CNTX Context Therapeutics	Initiates: Buy	$5	$0.88	+471.43%	1	Sep 18, 2025
	IDYA IDEAYA Biosciences	Initiates: Buy	$50	$24.44	+104.58%	1	Sep 18, 2025

Immatics

Sep 18, 2025

Initiates: Buy

Price Target: $16

Current: $6.03

Upside: +165.34%

Context Therapeutics

Sep 18, 2025

Initiates: Buy

Price Target: $5

Current: $0.88

Upside: +471.43%

IDEAYA Biosciences

Sep 18, 2025

Initiates: Buy

Price Target: $50

Current: $24.44

Upside: +104.58%